Non GMO: Petition to Stop FDA Approval of Transgenic Salmon - Deadline April 26

Although genetically modified crops have been part of the U.S. food supply for years, genetically modified animals have remained taboo. Now, a fast-growing salmon threatens to break that taboo, as it passes through the final stages required to become the first transgenic animal approved by the Food and Drug Administration for human consumption.
AquAdvantage is an Atlantic salmon, modified by the addition of a growth hormone gene from the Chinook salmon, and a genetic switch from an eel-like creature called the ocean pout. The switch keeps the growth hormone gene active all year, rather than only during warm weather. The genetically modified fish reach market weight in around 18 months, compared to three years for the natural Atlantic salmon.
The FDA tentatively concluded in 2010 that the fish would be safe to eat, and for the environment. In December, 2012, the agency released a “draft environmental assessment and preliminary finding of no significant impact,” effectively clearing the product’s path to enter the U.S. market, likely with no labeling to distinguish it from non GMO salmon. The FDA was scheduled to accept comments on their findings until February 25, but later extended the comment period until April 26.
GMO watchdogs Institute for Responsible Technology are petitioning the FDA not to approve GE salmon, and in the event that it is approved, require it to be labeled as genetically modified. If you are among the majority Americans who oppose introducing genetically modified meats into the food supply, sign the petition before the April 26 comment deadline.
For more information on our commitment to non GMO food, contact us.